China issues interim provisions on device recalls
This article was originally published in Clinica
Executive Summary
China's State Food and Drug Administration has promulgated interim provisions relating to its management of the medical device recall process. The new provisions, comprising six chapters and 38 articles, are due to come into effect on 1 July.